Product Information

IVABRADINE HCL 5 MG TABLET is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $0.7645 per EA under NDC 50742036260. Its NADAC has been published 96 times since Oct 23, 2024.

FDA first approved this application on Dec 30, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

IVABRADINE HCL 5 MG TABLET

IVABRADINE
$0.7645per EA

Strength

5 mg/1

NDC

50742036260

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

IVABRADINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA214051

FDA Approved

12/30/2021

TE Code

AB

On Market Since

7/15/2024

Pharmacological Classes

Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists
Hyperpolarization-activated Cyclic Nucleotide-gated Channel Blocker

Price Statistics

The NADAC for IVABRADINE HCL 5 MG TABLET has been published 96 times since Oct 23, 2024, and over the history we have for it it has declined 83.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.7645 per EA
All-time high$4.5638 (Nov 13, 2024)
All-time low$0.7645 (Aug 19, 2026)
52-week high$3.1866
52-week low$0.7645
Median price$3.0215
Average price$2.6174
Largest weekly change-40.9% (Feb 18, 2026)
Weeks tracked96
Tracking sinceOct 23, 2024

Price History

1W

-0.7%

1M

-0.7%

3M

-2.4%

6M

-16.9%

1Y

-76.0%

3Y

N/A

5Y

N/A

All

-83.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the IVABRADINE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of IVABRADINE HCL 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for IVABRADINE HCL 5 MG TABLET, manufactured by Ingenus Pharmaceuticals LLC, is $0.7645 per EA (NDC 50742036260), effective Aug 19, 2026.

How has the price of IVABRADINE HCL 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for IVABRADINE HCL 5 MG TABLET has declined 83.2%. It has been tracked across 96 weekly CMS publications since Oct 23, 2024.

What are the highest and lowest recorded NADAC prices for IVABRADINE HCL 5 MG TABLET?

Since Oct 23, 2024, the NADAC for IVABRADINE HCL 5 MG TABLET has ranged from a low of $0.7645 (Aug 19, 2026) to a high of $4.5638 (Nov 13, 2024), with a median of $3.0215 per EA.

Are there cheaper alternatives to IVABRADINE HCL 5 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of IVABRADINE HCL 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures IVABRADINE HCL 5 MG TABLET?

IVABRADINE HCL 5 MG TABLET (NDC 50742036260) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.